Skip to Content
UW Health SMPH
American Family Children's Hospital
Scott B. Perlman, MD close
Scott B. Perlman, MD

For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

Scott B. Perlman, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Perlman is the Chief of the Division of Nuclear Medicine and Director of the UW PET Imaging Center. His research interests include PET imaging in oncology and the use of positron emision tomography to evaluate inflammatory disease. Dr. Perlman provides a wide range of nuclear medicine services, including general nuclear medicine, nuclear cardiology, BMD and PET scans.



UW Health Clinics

UW Hospital and Clinics
(608) 263-8340 | (800) 323-8942 | Map
Wisconsin Institutes for Medical Research
(608) 265-8731 | Map

Hospital Affiliation(s)

University of Wisconsin Hospital and Clinics (primary)
Veterans Hospital - Wm. S. Middleton Memorial (secondary)

UW School of Medicine and Public Health

Department of Radiology

Professional Certifications and Education

Board Certification Nuclear Medicine
Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
Residency University of Wisconsin Hospital and Clinics, Madison, WI
Internship University of Wisconsin Hospital and Clinics, Madison, WI
Medical School The Chicago Medical School, Chicago, IL, 1980


Best Doctors® in America 2014

Best Doctors® in America 2013

Best Doctors® in America 2011

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Simoncic U Perlman S Liu G Jeraj R . Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer. Nucl Med Commun. 2015 Sep 16;
[PubMed ID: 26378490]
Bruce JY Scully PC Carmichael LL Eickhoff JC Perlman SB Kolesar JM Heideman JL Jeraj R Liu G . Pharmacodynamic study of axitinib in patients with advanced malignancies assessed with (18)F-3'deoxy-3'fluoro-L-thymidine positron emission tomography/computed tomography. Cancer Chemother Pharmacol. 2015 Jul;76(1):187-95
[PubMed ID: 26021741]
Simoncic U Perlman S Liu G Staab MJ Straus JE Jeraj R . Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastases. Clin Genitourin Cancer. 2015 Feb;13(1):e7-e17
[PubMed ID: 25128349]
Muzahir S Jeraj R Liu G Hall LT Rio AM Perk T Jaskowiak C Perlman SB . Differentiation of metastatic vs degenerative joint disease using semi-quantitative analysis with (18)F-NaF PET/CT in castrate resistant prostate cancer patients. Am J Nucl Med Mol Imaging. 2015;5(2):162-8
[PubMed ID: 25973337]
Schneider DF Sonderman PE Jones MF Ojomo KA Chen H Jaume JC Elson DF Perlman SB Sippel RS . Failure of radioactive iodine in the treatment of hyperthyroidism. Ann Surg Oncol. 2014 Dec;21(13):4174-80
[PubMed ID: 25001092]
Bruce JY Kolesar JM Hammers H Stein MN Carmichael L Eickhoff J Johnston SA Binger KA Heideman JL Perlman SB Jeraj R Liu G . A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies. Cancer Chemother Pharmacol. 2014 Mar;73(3):485-93
[PubMed ID: 24414551]
Bates ML Farrell ET Drezdon A Jacobson JE Perlman SB Eldridge MW . Hypoxia and exercise increase the transpulmonary passage of 99mTc-labeled albumin particles in humans. PLoS One. 2014;9(7):e101146
[PubMed ID: 25013985]
Perlman SB Hall BS Reichelderfer M . PET/CT imaging of inflammatory bowel disease. Semin Nucl Med. 2013 Nov;43(6):420-6
[PubMed ID: 24094709]
Vanderhoek M Perlman SB Jeraj R . Impact of different standardized uptake value measures on PET-based quantification of treatment response. J Nucl Med. 2013 Aug;54(8):1188-94
[PubMed ID: 23776199]
Nyflot MJ Harari PM Yip S Perlman SB Jeraj R . Correlation of PET images of metabolism, proliferation and hypoxia to characterize tumor phenotype in patients with cancer of the oropharynx. Radiother Oncol. 2012 Oct;105(1):36-40
[PubMed ID: 23068711]
Grayev AM Gentry LR Hartman MJ Chen H Perlman SB Reeder SB . Presurgical localization of parathyroid adenomas with magnetic resonance imaging at 3.0 T: an adjunct method to supplement traditional imaging. Ann Surg Oncol. 2012 Mar;19(3):981-9
[PubMed ID: 21879264]
Struck AF Hall LT Kusmirek JE Gallagher CL Floberg JM Jaskowiak CJ Perlman SB . (18)F-DOPA PET with and without MRI fusion, a receiver operator characteristics comparison. Am J Nucl Med Mol Imaging. 2012;2(4):475-82
[PubMed ID: 23145363]
Floberg JM Struck AF Peters BK Jaskowiak CJ Perlman SB Hall LT . Impact of expectation-maximization reconstruction iterations on the diagnosis of temporal lobe epilepsy with PET. Am J Nucl Med Mol Imaging. 2012;2(3):335-43
[PubMed ID: 23133820]
Vanderhoek M Perlman SB Jeraj R . Impact of the definition of peak standardized uptake value on quantification of treatment response. J Nucl Med. 2012 Jan;53(1):4-11
[PubMed ID: 22213818]
Liu G Jeraj R Vanderhoek M Perlman S Kolesar J Harrison M Simoncic U Eickhoff J Carmichael L Chao B Marnocha R Ivy P Wilding G . Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate. Clin Cancer Res. 2011 Dec 15;17(24):7634-44
[PubMed ID: 22038997]
Harrison MR Hahn NM Pili R Oh WK Hammers H Sweeney C Kim K Perlman S Arnott J Sidor C Wilding G Liu G . A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC). Invest New Drugs. 2011 Dec;29(6):1465-74
[PubMed ID: 20499131]
Struck AF Hall LT Floberg JM Perlman SB Dulli DA . Surgical decision making in temporal lobe epilepsy: a comparison of [(18)F]FDG-PET, MRI, and EEG. Epilepsy Behav. 2011 Oct;22(2):293-7
[PubMed ID: 21798813]
Lapp RT Spier BJ Perlman SB Jaskowiak CJ Reichelderfer M . Clinical utility of positron emission tomography/computed tomography in inflammatory bowel disease. Mol Imaging Biol. 2011 Jun;13(3):573-6
[PubMed ID: 20574849]
Vanderhoek M Juckett MB Perlman SB Nickles RJ Jeraj R . Early assessment of treatment response in patients with AML using [(18)F]FLT PET imaging. Leuk Res. 2011 Mar;35(3):310-6
[PubMed ID: 20832860]
Walker AJ Spier BJ Perlman SB Stangl JR Frick TJ Gopal DV Lindstrom MJ Weigel TL Pfau PR . Integrated PET/CT fusion imaging and endoscopic ultrasound in the pre-operative staging and evaluation of esophageal cancer. Mol Imaging Biol. 2011 Feb;13(1):166-71
[PubMed ID: 20379789]